Peter Terness
Institute of Immunology
University of Heidelberg
Department of Transplantation Immunology
Heidelberg
Germany
Name/email consistency: high
- Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside. Terness, P., Kleist, C., Simon, H., Sandra-Petrescu, F., Ehser, S., Chuang, J.J., Mohr, E., Jiga, L., Greil, J., Opelz, G. Hum. Immunol. (2009)
- Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases. Terness, P., Oelert, T., Ehser, S., Chuang, J.J., Lahdou, I., Kleist, C., Velten, F., Hämmerling, G.J., Arnold, B., Opelz, G. Proc. Natl. Acad. Sci. U.S.A. (2008)
- The immunoregulatory role of IDO-producing human dendritic cells revisited. Terness, P., Chuang, J.J., Opelz, G. Trends Immunol. (2006)
- Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?. Terness, P., Chuang, J.J., Bauer, T., Jiga, L., Opelz, G. Blood (2005)